Sunday 11 October 2026 Export all RLYB data to Excel Powerpack

Rallybio Corporation

RLYB Healthcare Biotechnology

In the quarter to June 2026, revenue was flat, EPS grew 535.2% and free cash flow grew 648.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

17.02 0.03 +0.18%
Market cap
$90.2M
P/E
2.1×
Fwd P/E
−3.5×
Dividend yield
—
F-score
n/a
Altman Z
−3.12
Beneish M
n/a
Dividend safety
n/a
Dec '17 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
— — — — — — 0.00 0.00
P/S ratio
— — — — — — 0.00 36.02
Altman Z-Score
— — — — — — (3.97) (3.12)
P/FCF ratio
— — — — — — 0.00 0.00
Altman Z″-Score (non-manufacturers)
— — — — — — (4.03) 0.76
P/Operating CF
— — — — — — (4.24) (6.61)
P/B ratio
— — — — — — 0.68 0.53
Price to Tangible BV
— — — — — — 0.68 0.53
EV/Sales
— — — — — — 0.00 (27.77)
EV/EBITDA
— — — — — — 0.38 0.71
EV/Operating CF
— — — — — — 0.48 0.80
EV/FCF
— — — — — — 0.48 0.80
Quick Ratio
— 5.11 24.00 26.76 15.73 11.87 10.50 12.96
Current Ratio
— 5.50 24.18 27.61 16.71 12.39 10.87 14.50
Net Debt/EBITDA
— 1.10 5.56 3.85 2.48 1.34 1.06 1.63
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
— 0.00 0.00 0.00 0.00 0.00 0.01 0.01
Operating CF/Net income
— 0.86 0.83 0.97 0.86 0.81 0.85 3.32
Capex/Depreciation
— 0.00 (2.21) (3.05) 0.20 0.00 0.00 0.00
Interest Coverage
— (149.51) (516.39) (4,564.80) (34.58) — — —
ROE
— 0.00% (45.71%) (30.17%) (38.65%) (54.13%) (68.85%) (15.01%)
ROA
— (162.57%) (32.36%) (29.02%) (36.76%) (50.37%) (62.89%) (13.77%)
ROIC
— 0.00% 0.00% (10,645.52%) (13,135.45%) 0.00% 0.00% (641.77%)
Return on Tangible Assets
— (101.44%) (19.49%) (26.89%) (39.41%) (70.50%) (93.62%) (15.74%)
Average Days of Receivables
— — — — — — 0.00 0.00
Research and Development Expense of Revenue
— 0.00% 0.00% 0.00% 0.00% 0.00% 6,526.26% 2,284.03%
Selling, General and Administrative Expense of Revenue
— 0.00% 0.00% 0.00% 0.00% 0.00% 3,085.69% 1,669.58%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
— — 0.00% 0.00% 0.00% 0.00% 1,256.76% 619.35%
Graham Net Nets
— — — — — — 1.47 1.84
Graham Number
— — — — — — 0.00 0.00
Earnings Yield
— — — — — — (140.63%) (28.80%)
Free Cash Flow Yield
— — — — — — (117.96%) (96.55%)
Revenue per Share
— 0.00 0.00 0.00 0.00 0.00 0.12 0.15
Operating CF per Share
— (0.47) (10.14) (14.27) (14.40) (11.92) (9.05) (5.30)
Capex per Share
— 0.00 (0.06) (0.10) (0.01) 0.00 0.00 0.00
Free Cash Flow per Share
— (0.47) (10.20) (14.38) (14.42) (11.92) (9.05) (5.30)
Cash per Share
— 0.61 64.52 54.97 42.49 21.74 12.04 9.72
Shareholders Equity per Share
— 0.52 62.57 55.05 42.57 21.00 11.33 10.29
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
— 0.52 62.57 55.05 42.57 21.00 11.33 10.29
Free Cash Flow
— (15.03) (22.18) (45.87) (57.34) (60.28) (49.28) (29.81)
Working Capital
— 17.11 135.42 174.32 168.75 105.53 61.60 57.03
Capital Expenditures
— (0.19) (0.14) (0.33) (0.05) (0.01) — —
Net Current Asset Value
— 16.17 135.41 174.29 168.38 105.35 61.39 56.95
EV/EBIT
— — — — — — 0.39 0.72
Capex to Sales
— — 0.00 0.00 0.00 0.00 0.00 0.00
Price to Operating Income
— — — — — — 0.00 0.00
Other line items
Depreciation/Fixed assets
— 0.13 0.22 0.21 (0.70) (11.95) (12.88) (20.91)
Cash ROIC
— (41.37%) (8.03%) (13.07%) (16.95%) (27.89%) (38.75%) (26.46%)
Accounts Receivable Turnover
— — — — — — 0.00 0.00
Accounts Payable Turnover
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
— 0.00 0.00 0.00 0.00 — — —
Average Days of Payables
— 11,893.73 0.00 0.00 0.00 0.00 0.00 0.00
Days of Inventory on Hand
— 0.00 0.00 0.00 0.00 — — —
Average Payables
— — 1.22 1.09 0.86 1.05 0.63 0.20
Average Assets
— 10.80 81.73 162.02 181.31 148.03 91.86 65.18
Average Common Equity
— — 57.86 155.80 172.46 137.75 83.92 59.81

Fold the line items

Columns are period end dates